The Pharmacogenomics Journal - Table of Contents alert Volume 14 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 14, Issue 3 (June 2014) In this issue Consensus Article Original Articles Also new AOP Webinar: Using Disease Mutations and PGx Variants to Personalize Patient Diagnosis and Treatment Learn to leverage the well-known approach of matching a patient's genome to known disease causing mutations in order to identify the genetic basis behind disease in combination with selecting optimal treatment strategy basing on patient's pharmacogenomic variants. Address the challenge of screening patients for actionable variants Identify disease variants with HGMD® Identify best treatments via PGMD™ Register Today! Sign up for e-alerts Recommend to your library Web feed Subscribe NOW AVAILABLE: Discounts on lab equipment Savings and information - all in one place! Check Marketplace before you buy Browse LAB OFFERS and PRODUCT FOCUS     Consensus Article Top Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes J Graessler, T D Bornstein, D Goel, V P Bhalla, T Lohmann, T Wolf, M Koch, Y Qin, J Licinio, M-L Wong, T Chavakis, A Xu, A Shevchenko, K Schuhmann, P E H Schwarz, K-M Schulte, A Patel and S R Bornstein Pharmacogenomics J 2014 14: 201-207; advance online publication, December 24, 2013; 10.1038/tpj.2013.42 Abstract | Full Text Original Articles Top Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity OPEN J D Zhang, N Berntenis, A Roth and M Ebeling Pharmacogenomics J 2014 14: 208-216; advance online publication, November 12, 2013; 10.1038/tpj.2013.39 Abstract | Full Text Pharmacogenomics, ancestry and clinical decision making for global populations E Ramos, A Doumatey, A G Elkahloun, D Shriner, H Huang, G Chen, J Zhou, H McLeod, A Adeyemo and C N Rotimi Pharmacogenomics J 2014 14: 217-222; advance online publication, July 9, 2013; 10.1038/tpj.2013.24 Abstract | Full Text Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans W Hernandez, E R Gamazon, K Aquino-Michaels, S Patel, T J O'Brien, A F Harralson, R A Kittles, A Barbour, M Tuck, S D McIntosh, J N Douglas, D Nicolae, L H Cavallari and M A Perera Pharmacogenomics J 2014 14: 223-228; advance online publication, September 10, 2013; 10.1038/tpj.2013.34 Abstract | Full Text Interethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and Spain A Llerena, M Alvarez, P Dorado, I González, E Peñas-LLedó, B Pérez, J Cobaleda and L R Calzadilla Pharmacogenomics J 2014 14: 229-234; advance online publication, August 20, 2013; 10.1038/tpj.2013.28 Abstract | Full Text Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South Australia M M Dias, H M Ward, M J Sorich and R A McKinnon Pharmacogenomics J 2014 14: 235-240; advance online publication, September 10, 2013; 10.1038/tpj.2013.31 Abstract | Full Text Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer S Yao, L E Sucheston, H Zhao, W E Barlow, G Zirpoli, S Liu, H C F Moore, G Thomas Budd, D L Hershman, W Davis, G L Ciupak, J A Stewart, C Isaacs, T J Hobday, M Salim, G N Hortobagyi, J R Gralow, R B Livingston, K S Albain, D F Hayes and C B Ambrosone Pharmacogenomics J 2014 14: 241-247; advance online publication, September 3, 2013; 10.1038/tpj.2013.32 Abstract | Full Text Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel A K Koutras, V Kotoula, C Papadimitriou, D Dionysopoulos, F Zagouri, H P Kalofonos, H P Kourea, D V Skarlos, E Samantas, K Papadopoulou, P Kosmidis, D Pectasides and G Fountzilas Pharmacogenomics J 2014 14: 248-255; advance online publication, September 24, 2013; 10.1038/tpj.2013.36 Abstract | Full Text Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan A Sebio, D Páez, J Salazar, A Berenguer-Llergo, L Paré-Brunet, A Lasa, E del Río, M Tobeña, M Martín-Richard, M Baiget and A Barnadas Pharmacogenomics J 2014 14: 256-262; advance online publication, August 20, 2013; 10.1038/tpj.2013.29 Abstract | Full Text The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation C R S Uppugunduri, M A Rezgui, P H Diaz, A K Tyagi, J Rousseau, Y Daali, M Duval, H Bittencourt, M Krajinovic and M Ansari Pharmacogenomics J 2014 14: 263-271; advance online publication, October 29, 2013; 10.1038/tpj.2013.38 Abstract | Full Text Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial S L Charland, B C Agatep, V Herrera, B Schrader, F W Frueh, M Ryvkin, J Shabbeer, J J Devlin, H R Superko and E J Stanek Pharmacogenomics J 2014 14: 272-280; advance online publication, August 27, 2013; 10.1038/tpj.2013.27 Abstract | Full Text HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis E Genin, D-P Chen, S-I Hung, P Sekula, M Schumacher, P-Y Chang, S-H Tsai, T-L Wu, T Bellón, R Tamouza, C Fortier, A Toubert, D Charron, A Hovnanian, P Wolkenstein, W-H Chung, M Mockenhaupt and J-C Roujeau Pharmacogenomics J 2014 14: 281-288; advance online publication, December 10, 2013; 10.1038/tpj.2013.40 Abstract | Full Text Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson’s disease patients A F Schumacher-Schuh, V Altmann, M Rieck, L Tovo-Rodrigues, T L Monte, S M Callegari-Jacques, M S Medeiros, C R M Rieder and M H Hutz Pharmacogenomics J 2014 14: 289-294; advance online publication, October 15, 2013; 10.1038/tpj.2013.37 Abstract | Full Text Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders OPEN J T McCracken, K K Badashova, D J Posey, M G Aman, L Scahill, E Tierney, L E Arnold, B Vitiello, F Whelan, S Z Chuang, M Davies, B Shah, C J McDougle and E L Nurmi Pharmacogenomics J 2014 14: 295-302; advance online publication, July 16, 2013; 10.1038/tpj.2013.23 Abstract | Full Text Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females T-K Clarke, R C Crist, A Ang, L M Ambrose-Lanci, F W Lohoff, A J Saxon, W Ling, M P Hillhouse, R D Bruce, G Woody and W H Berrettini Pharmacogenomics J 2014 14: 303-308; advance online publication, October 15, 2013; 10.1038/tpj.2013.30 Abstract | Full Text   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.